Ose Immunotherapeutics

Developer of immunotherapies for immuno-oncology and autoimmune diseases

placeNantes, Pays De La Loire, France calendar_todayFounded 1986 groups61 employees language ose-immuno.com

Innovation

71 patent families (26 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 5,539 times.

YearFilings
20151
20164
201711
201814
201918
202022
202127
202227
202329
202435
202531
202613

Social engagement

Social engagement: 21K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Bank & private debt150%

Recent activity

1 Jul 2026
Event
Assemblée Générale 2026
22 Jan 2026
Milestone
regulatory
22 Jan 2026
Milestone
regulatory
Coming soon